IDXX

IDEXX Laboratories, Inc.

Healthcare
550.82 -15.97 -2.82% Market Closed
2026-06-02 • USD

Key Metrics

Market Cap 43.45B
EV —
Shares Out 78.88M
Revenue (ttm) 4.45B
Net Income 1.10B
Beta —
P/E 38.45
Forward P/E —
EPS (ttm) $13.59
P/S —
P/B 28.19
P/FCF —
P/C —
EV/Sales —
EV/EBITDA —
ROA 32.35%
ROE 72.65%
ROIC —
Gross Margin 62.05%
Oper. Margin 31.63%
Profit Margin 24.63%
Debt/Eq 0.37
LT Debt/Eq 16.16%
Quick Ratio —
Current Ratio 1.12
Book/sh 19.54
Cash/sh 2.52
Div Yield —
Div TTM —
Payout Ratio —
SMA20 -0.27%
SMA50 -2.31%
SMA200 -13.56%
Volume 669,227
Avg Volume 564.00K
Rel Volume —
Perf Week -2.26%
Perf Month -2.16%
Perf Quarter -11.00%
Perf Half Y -22.87%
Perf YTD -18.58%
Perf Year 5.48%
Perf 3Y 18.38%
Perf 5Y -1.35%

Factor Lens

Seasonal Performance

Financial Trends

Revenue & Net Income

Earnings Per Share

Margins

Cash Flow

Company Overview

IDEXX Laboratories, Inc. is a global diagnostics and software company serving veterinary healthcare, water microbiology and livestock and poultry diagnostics markets. The company operates through three reportable segments: Companion Animal Group (CAG) Diagnostics, which provides veterinary diagnostic products, services and software solutions including instruments, consumables, reference laboratory services, and practice management systems; Water segment, providing water microbiology testing products; and Livestock, Poultry and Dairy (LPD) segment, offering diagnostic products and services for livestock and poultry health. The company's CAG Diagnostics segment generates approximately 79% of total revenue and includes recurring revenue from diagnostic instruments, consumables, and subscription-based software and services. IDEXX has invested over $2.5 billion in research and development since 1998 to develop innovative diagnostic platforms including the IDEXX inVue Dx Cellular Analyzer, Catalyst chemistry analyzers, SediVue Dx urine analyzer, and reference laboratory diagnostic services. The company also provides cloud-based practice management systems and pet-owner engagement software solutions. IDEXX serves veterinarians, veterinary practices, water quality testing laboratories, and livestock producers globally.

Name
IDEXX Laboratories, Inc.
Industry
Diagnostics & Research
CEO
Jonathan J. Mazelsky · President and Chief Executive Officer
Employees
—
IPO Date
2014-11-19
Phone
(207) 556-0300
Address
One IDEXX Drive, Westbrook, ME 04092
Website
www.idexx.com

Key Executives

Name Title FY Pay
Jay Mazelsky President and CEO (Current as of filing date) —
Annette Catino Chief Financial Officer —
Sharon E. Underberg Executive Vice President, General Counsel and Corporate Secretary —
Michael G. Erickson, PhD Chief Innovation Officer and President, Companion Animal Group Diagnostics —
Jonathan J. Mazelsky President and Chief Executive Officer —

Latest News